1 October 2023 in Arteriosclerosis, Thrombosis, and Vascular Biology
BACKGROUND: We hypothesized that transcriptomic profiling of muscle satellite cells in peripheral artery disease (PAD) would identify damage-related pathways contributing to skeletal muscle myopathy. We identified a potential role for ferroptosis—a form of programmed lytic cell death by iron-mediated lipid peroxidation—as one such pathway. Ferroptosis promotes myopathy in ischemic cardiac muscle but has an unknown role in PAD. METHODS: Muscle satellite cells from donors with PAD were obtained during surgery. cDNA libraries were processed for single-cell RNA sequencing using the 10X Genomics platform. Protein expression was confirmed based on pathways inferred by transcriptomic analysis. RESULTS: Unsupervised cluster analysis of over 25 000 cells aggregated from 8 donor samples yielded distinct cell populations grouped by a shared unique transcriptional fingerprint. Quiescent cells were diminished in ischemic muscle while myofibroblasts and apoptotic cells were prominent. Differential gene expression demonstrated a surprising increase in genes associated with iron transport and oxidative stress and a decrease in GPX4 (glutathione peroxidase 4) in ischemic PAD-derived cells. Release of the danger signal HMGB1 (high mobility group box-1) correlated with ferroptotic markers including surface transferrin receptor and were higher in ischemia. Furthermore, lipid peroxidation in muscle satellite cells was modulated by ferrostatin, a ferroptosis inhibitor. Histology confirmed iron deposition and lipofuscin, an inducer of ferroptosis in PAD-affected muscle. CONCLUSIONS: This report presents a novel finding that genes known to be involved in ferroptosis are differentially expressed in human skeletal muscle affected by PAD. Targeting ferroptosis may be a novel therapeutic strategy to reduce PAD myopathy.
13 December 2022 in Journal of Vascular Surgery
18 June 2025 in Journal of Vascular Surgery
Aortic infection is associated with high morbidity and mortality, but the outcomes of prosthetic (surgical or endovascular) grafts compared to primary aortic infections are poorly defined. This large single-center retrospective study aims to compare the outcomes of primary and prosthetic aortic graft infections. Patients diagnosed with primary or infected aortic grafts between January 2000 and December 2022 were included. Patients were grouped based on the type of infection (primary, surgical graft and endograft). Baseline demographics, symptoms, imaging, interventions, and outcomes were evaluated. Primary outcomes include overall and reintervention-free survival. Kaplan-Meier survival and Cox proportional hazards analysis were performed. A total of 145 patients presented during the study period with primary infection of the native aorta (33.8%) or aortic graft infection (66.2%: 44.8% surgical graft and 21.4% endograft). In-hospital mortality (39% vs. 15% vs. 10%, p=.007) and 30-day complication rates (68% vs. 40% vs. 37%, p=.015) were highest among endografts, followed by surgical grafts, and lowest among primary infections respectively (Table I). Primary aortic infections had the highest 30-day, 1-year, and 5-year survival on Kaplan Meier analysis compared to surgical and endograft infections (Figures 1, 2, and 3). Reintervention-free survival was also highest in primary infections at 1 and 5 years (log-rank p<.001). On multi-variate analysis, infected surgical grafts and endografts were associated with a significantly higher 30-day mortality (HR 8.1, p=.016 and HR 5.8, p=.035 respectively). Visceral artery involvement was a major determinant of mortality at 1-year and 5-years but not at 30-days, while treatment type did not affect mortality across all groups. There was no difference in the duration of intravenous antibiotic treatment between groups (42 vs. 45 vs. 44 days; p=.68). Infected aortic endografts have lower short and long-term survival as well as a lower rate of long-term intervention-free survival when compared to surgical graft and primary aortic infections. Visceral artery involvement was associated with increased mortality. Predictors of endograft infection need to be determined to minimize complications and careful consideration is necessary before endovascular aortic interventions if there is concern an underlying infectious process.
3 April 2022 in Biochemical and Biophysical Research Communications